Law360, New York (May 26, 2009, 12:00 AM ET) -- A group of investors led by two public pension funds from Oklahoma and two European investment management firms has been chosen to serve as lead plaintiff in a securities class action against Medtronic Inc. alleging losses stemming from off-label use of its InFuse spinal graft product.
Judge Paul A. Magnuson of the U.S. District Court for the District of Minnesota signed off Tuesday on a magistrate judge's report suggesting that the Medtronic Institutional Investor Group — which consists of the Teachers Retirement System of Oklahoma, the...
Lead Plaintiff Chosen In Medtronic Securities Suit
To view the full article, take a free trial now.
